P Aukrust

702 total citations
16 papers, 506 citations indexed

About

P Aukrust is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Molecular Biology. According to data from OpenAlex, P Aukrust has authored 16 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in P Aukrust's work include Platelet Disorders and Treatments (2 papers), Chemokine receptors and signaling (2 papers) and Inflammasome and immune disorders (2 papers). P Aukrust is often cited by papers focused on Platelet Disorders and Treatments (2 papers), Chemokine receptors and signaling (2 papers) and Inflammasome and immune disorders (2 papers). P Aukrust collaborates with scholars based in Norway and United States. P Aukrust's co-authors include Arne Yndestad, Erik Øie, S S Frøland, Lars Gullestad, Torill Ueland, Terje Espevik, Linn Landrø, Trude Helen Flo, Cathrine Husberg and J. Kjekshus and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and European Heart Journal.

In The Last Decade

P Aukrust

14 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Aukrust Norway	9	125	120	118	111	85	16	506
Rianne M. Jongman Netherlands	18	108 0.9×	163 1.4×	106 0.9×	164 1.5×	145 1.7×	35	602
Khaled F. Salhab United States	11	157 1.3×	61 0.5×	80 0.7×	92 0.8×	93 1.1×	24	461
Álvaro Aceña Spain	13	119 1.0×	54 0.5×	132 1.1×	80 0.7×	41 0.5×	43	374
Amber P. Sanchez United States	11	108 0.9×	129 1.1×	37 0.3×	106 1.0×	41 0.5×	20	583
Estêvão Bassi Brazil	9	66 0.5×	44 0.4×	137 1.2×	158 1.4×	123 1.4×	18	531
Nithya Krishnan United States	16	140 1.1×	124 1.0×	66 0.6×	232 2.1×	47 0.6×	43	695
Joseph Zullo United States	9	133 1.1×	47 0.4×	41 0.3×	148 1.3×	82 1.0×	12	554
Noriko Kishimoto Japan	14	146 1.2×	42 0.3×	70 0.6×	232 2.1×	123 1.4×	22	675
Helena Gil‐Peña Spain	17	286 2.3×	51 0.4×	41 0.3×	332 3.0×	49 0.6×	51	755
Lawrence R. Shoemaker United States	15	55 0.4×	34 0.3×	60 0.5×	153 1.4×	53 0.6×	35	520

Countries citing papers authored by P Aukrust

Since Specialization

Citations

This map shows the geographic impact of P Aukrust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Aukrust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Aukrust more than expected).

Fields of papers citing papers by P Aukrust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Aukrust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Aukrust. The network helps show where P Aukrust may publish in the future.

Co-authorship network of co-authors of P Aukrust

This figure shows the co-authorship network connecting the top 25 collaborators of P Aukrust. A scholar is included among the top collaborators of P Aukrust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Aukrust. P Aukrust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Øverland, Britt, Christina Bendz, Annika E. Michelsen, et al.. (2025). Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation. European Journal of Internal Medicine. 139. 106363–106363.

Hoel, Henrik, Lars Heggelund, Dag Henrik Reikvam, et al.. (2020). Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement. Journal of Internal Medicine. 289(4). 523–531. 71 indexed citations

Ueland, Thor, P Aukrust, Annika E. Michelsen, et al.. (2017). The Immediate Response in Markers of Inflammation and Angiogenesis During Exercise in Heart Transplant Recipients. The Journal of Heart and Lung Transplantation. 36(4). S395–S395. 2 indexed citations

Larsen, Alf Inge, Sigurd Lindal, Jan Terje Kvaløy, et al.. (2013). Cardiac resynchronization therapy improves minute ventilation/carbon dioxide production slope and skeletal muscle capillary density without reversal of skeletal muscle pathology or inflammation. EP Europace. 15(6). 857–864. 8 indexed citations

Broch, Kaspar, et al.. (2012). Heart failure biomarkers: focus on interleukin-1 receptor-like1-based blood tests. Drugs of today. 48(7). 479–479. 12 indexed citations

Midtvedt, Øyvind, et al.. (2010). Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature. Scandinavian Journal of Rheumatology. 40(1). 74–79. 25 indexed citations

Kjekshus, J., et al.. (2010). 599 C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?. European Journal of Cancer Supplements. 8(5). 152–153.

Yndestad, Arne, Linn Landrø, Torill Ueland, et al.. (2009). Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. European Heart Journal. 30(10). 1229–1236. 235 indexed citations

Ueland, Thor, et al.. (2009). Perfusion temperature, thyroid hormones and inflammation during pediatric cardiac surgery. Interactive Cardiovascular and Thoracic Surgery. 10(1). 76–80. 7 indexed citations

10.

Smith, Camilla, Bente Halvorsen, Kari Otterdal, et al.. (2008). High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. Cardiovascular Research. 79(1). 195–203. 46 indexed citations

11.

Bjerkeli, Vigdis, Jan Kristian Damås, Børre Fevang, et al.. (2007). Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis possible role in vascular inflammation. Lara D. Veeken. 46(9). 1422–1427. 38 indexed citations

12.

Ueland, Thor, et al.. (2003). Interleukin-1 Receptor Antagonist Is Associated with Fat Distribution in Endogenous Cushing’s Syndrome: A Longitudinal Study. The Journal of Clinical Endocrinology & Metabolism. 88(4). 1492–1496. 33 indexed citations

13.

Hognestad, Aina, Annika E. Michelsen, Frank Brosstad, et al.. (2002). Platelet activation in heart transplant recipients. The Journal of Heart and Lung Transplantation. 21(1). 97–98. 3 indexed citations

14.

Gullestad, Lars & P Aukrust. (2001). The cytokine network in heart failure: pathogenetic importance and potential therapeutic targets.. PubMed. 2(1). 8–13. 17 indexed citations

15.

Aukrust, P, Frøland Ss, Felix Müller, et al.. (1994). Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood. 84(7). 2136–2143. 7 indexed citations

16.

Mølstad, Per, et al.. (1992). Left atrial myxoma and systemic AL-amyloidosis. European Heart Journal. 13(1). 143–144. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact